CLINICAL_TRIALS
trial_result
· 2015-03-24
Clinical Trial Update: Ciclosporin in the Management of New Type 1 Reactions in Leprosy [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 study evaluating cyclosporine for the management of Type 1 reactions in leprosy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Leprosy | Phase 2, Phase 3 | Status: COMPLETED